Search research articles
Contact Us
Filters
Showing results (831-840 of 932) with videos related to
Page
of 94
Sort By:
Molecular Oncology
|
February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Rory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
European Urology
|
February 11, 2026
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide
Paul L Nguyen, Marisa A Kollmeier, Dana E Rathkopf, et al.
The Prostate
|
November 16, 2022
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer
Christopher T Su, Emily Nizialek, Jacob E Berchuck, et al.
The Journal of Urology
|
March 8, 2021
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
Rana R McKay, Wanling Xie, Huihui Ye, et al.
JCO Precision Oncology
|
February 15, 2019
Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
Maria I Carlo, Veda N Giri, Channing J Paller, et al.
The Oncologist
|
October 22, 2025
Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617
Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes
Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Cancer Research Communications
|
May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
Carly D Miller, John R Lozada, Nicholas A Zorko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
Charles B Nguyen, Melissa A Reimers, Chamila Perera, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Page
of 94
Search research articles
Search
Showing results (831-840 of 932) with videos related to
Sort By:
Page
of 94
Molecular Oncology
|
February 19, 2021
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma
Rory M Bade, Jennifer L Schehr, Hamid Emamekhoo, et al.
European Urology
|
February 11, 2026
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide
Paul L Nguyen, Marisa A Kollmeier, Dana E Rathkopf, et al.
The Prostate
|
November 16, 2022
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer
Christopher T Su, Emily Nizialek, Jacob E Berchuck, et al.
The Journal of Urology
|
March 8, 2021
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer
Rana R McKay, Wanling Xie, Huihui Ye, et al.
JCO Precision Oncology
|
February 15, 2019
Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium
Maria I Carlo, Veda N Giri, Channing J Paller, et al.
The Oncologist
|
October 22, 2025
Genomic Alterations and Associated Outcomes in Patients with PSMA-Positive Metastatic Castration-Resistant Prostate Cancer treated with 177Lu-PSMA-617
Justine Panian, Nicholas C Henderson, Daniel Herchenhorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes
Justin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.
Cancer Research Communications
|
May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
Carly D Miller, John R Lozada, Nicholas A Zorko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 24, 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
Charles B Nguyen, Melissa A Reimers, Chamila Perera, et al.
The Oncologist
|
June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy
Justine Panian, Ava Saidian, Kevin Hakimi, et al.
Page
of 94